NEW YORK ( TheStreet) -- C.R. Bard (NYSE: BCR) hit a new 52-week high Friday as it traded at $99 compared with its previous 52-Week high of $98.68. C.R. Bard is changing hands at $98.20 with 694,236 shares traded as of 2:26 p.m. ET. Average volume has been 629,700 shares over the past 30 days. C.R. Bard has a market cap of $9.1 billion and is part of the health care sector and health services industry. Shares are up 6.5% year to date as of the close of trading on Thursday.

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company has a P/E ratio of 17.5, below the average health services industry P/E ratio of 18.4 and below the S&P 500 P/E ratio of 23.4.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, increase in stock price during the past year and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full C.R. Bard Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.